A modern clinic for at-home treatments
(857) 240-1080
Holiday Sale! Get started today for only
$49 $4.99
Written and prepared by:
Aaron Michael Taylor, Jianting Sheng, Patrick Kwok Shing Ng, Jeffrey M. Harder, Parveen Kumar, Ju Young Ahn, Yuliang Cao, Alissa M. Dzis, Nathaniel L. Jillette, Andrew Goodspeed, Avery Bodlak, Qian Wu, Michael S. Isakoff, Joshy George, Jessica D.S. Grassmann, Diane Luo, William F. Flynn, Elise T. Courtois, Paul Robson, Masanori Hayashi, Alini Trujillo Paolillo, Antonio Sergio Petrilli, Silvia Regina Caminada de Toledo, Fabiola Sara Balarezo, Adam D. Lindsay, Bang Hoang, Stephen T.C. Wong, Ching C. Lau
Delve into the immunosuppressive tumor microenvironment of osteosarcoma, the most common malignant bone tumor in children. This study uses single-cell RNA sequencing and spatial transcriptomics to analyze tumor biopsy samples, revealing immunosuppressive cells like myeloid-derived suppressor cells (MDSCs) and exhausted T-cells. It highlights robust interactions between these cells, promoting tumor progression and an immunosuppressive microenvironment, underscoring the need for novel immunotherapies targeting these mechanisms.
Study explores the immunosuppressive tumor microenvironment in osteosarcoma using single-cell RNA sequencing.
Identifying the role of MDSCs and their interactions in promoting immunosuppression in osteosarcoma.
Spatial transcriptomics reveals immune cell distribution and interactions within osteosarcoma tumors.
Examining the impact of regulatory T cells on osteosarcoma progression and immunosuppressive pathways.
Study identifies diverse macrophage subtypes contributing to the immunosuppressive environment in osteosarcoma.
Highlighting potential immunotherapy targets within the osteosarcoma microenvironment to improve treatment outcomes.
Insurance covers clinical consultations.
Subscription fee (from $59/month not billed to insurance) covers immunotherapy, shipping & related costs.